Free Trial
LON:TRS

Tarsus Group (TRS) Share Price, News & Analysis

GBX 424
-0.50 (-0.12%)
(As of 08/14/2019)
Today's Range
424
424
50-Day Range
424
424
52-Week Range
237
438
Volume
215,764 shs
Average Volume
272,972 shs
Market Capitalization
£549.84 million
P/E Ratio
45.59
Dividend Yield
0.03%
Price Target
N/A
TRS stock logo

About Tarsus Group Stock (LON:TRS)

Tarsus Group plc, an integrated media company, engages in exhibitions, conferences, publishing, education, and Internet activities. It operates through three segments: EMEA, Americas, and Asia. The company owns and manages a portfolio of trade exhibitions; and reinforces its trade shows through online interaction and education; and provides publications and thought leadership conferences. It conducts events for medical, meeting, labels and printing, packaging, fashion, industrial and manufacturing, media, automotive, finance and technology, food and hospitality, infrastructure, education, musical instruments, travel and leisure, housewares and interior design, aerospace, and construction industries. The company's primary brands include the Dubai Airshow, Labelexpo, Automotive Aftermarket Industry and Tuning Trade Fair, Zuchex, ASANSÖR, Tarsus Medical, OFFPRICE, Global Educational Supplies and Solutions, China (Shenzhen) International Brand Underwear Fair, CES Asia, Connect, Music China, Hometex, Expo Manufactura, Indonesia Infrastructure Week, and WOFEX. Tarsus Group plc was founded in 1998 and is headquartered in Dublin, Ireland.

TRS Stock Price History

TRS Stock News Headlines

Musk’s new company could top a trillion?
The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just released the details on what he’s calling Elon’s Project X-9840.
TriMas Corp.
Tarsus Pharmaceuticals, Inc. (TARS)
Musk’s new company could top a trillion?
The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just released the details on what he’s calling Elon’s Project X-9840.
Tarsus Pharmaceuticals's Earnings: A Preview
Recap: Tarsus Pharmaceuticals Q3 Earnings
Expert Ratings for Tarsus Pharmaceuticals
See More Headlines
Receive TRS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tarsus Group and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Advertising Agencies
Sub-Industry
Fabricated Products
CIK
N/A
Fax
N/A
Employees
3,500
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£99.73 million
Book Value
GBX 77.80 per share

Miscellaneous

Free Float
N/A
Market Cap
£549.84 million
Optionable
Not Optionable
Beta
N/A
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Mr. Neville David Buch (Age 73)
    Exec. Chairman
  • Mr. James Douglas Emslie (Age 52)
    Group MD & Exec. Director
  • Mr. Daniel P. O'Brien (Age 52)
    Group Fin. Director & Exec. Director
  • Mr. Simon Smith (Age 43)
    Head of Corp. Affairs & Company Sec.
  • Mr. William Jage
    Chairman & CEO of Off-Price Specialist Center Inc

TRS Stock Analysis - Frequently Asked Questions

How have TRS shares performed this year?

Tarsus Group's stock was trading at GBX 424 on January 1st, 2024. Since then, TRS shares have increased by 0.0% and is now trading at GBX 424.
View the best growth stocks for 2024 here
.

How do I buy shares of Tarsus Group?

Shares of TRS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What other stocks do shareholders of Tarsus Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Tarsus Group investors own include Avery Dennison (AVY), Aviva (AV), Fidelity Japan Trust (FJV), Hotel Chocolat Group (HOTC), HSBC (HSBA), Primary Health Properties (PHP) and Royal Dutch Shell (RDSB).

This page (LON:TRS) was last updated on 9/16/2024 by MarketBeat.com Staff

From Our Partners